Sujay Singh
Overview
Explore the profile of Sujay Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee H, Solitano V, Singh S, Ananthakrishnan A, Jairath V, Syal G, et al.
Clin Gastroenterol Hepatol
. 2024 Dec;
PMID: 39732355
Background And Aims: We sought to ascertain how prior exposure to tumor necrosis factor (TNF) antagonists impacts treatment response with various classes of advanced therapies in patients with ulcerative colitis...
2.
Madan E, Palma A, Vudatha V, Kumar A, Bhoopathi P, Wilhelm J, et al.
Nat Biotechnol
. 2024 Dec;
PMID: 39653752
Cell competition and fitness comparison between cancer and tumor microenvironment (TME) cells determine oncogenic fate. Our previous study established a role for human Flower isoforms as fitness fingerprints, where the...
3.
Patra A, Nayak S, Moharana A, Ojha P, Das S, Akhtar J, et al.
Biologics
. 2024 Sep;
18:257-271.
PMID: 39319321
Purpose: The study aimed to develop and characterize Indikizumab, a novel humanized anti-IL-17A monoclonal antibody (mAb), for potential therapeutic use in inflammatory indications such as psoriasis, psoriatic arthritis, rheumatoid arthritis,...
4.
Ojha P, Kar N, Behera H, Parija M, Nayak S, Singh S, et al.
3 Biotech
. 2023 Jun;
13(7):240.
PMID: 37337524
In this study, we evaluated the independent anticancer properties of a novel heat-stable lysozyme derived from the thermophilic bacterium (BplzC) to identify potential alternative therapies to address the suboptimal outcomes...
5.
Sayed I, Suarez K, Lim E, Singh S, Pereira M, Ibeawuchi S, et al.
FEBS J
. 2020 Feb;
287(18):3967-3988.
PMID: 32003126
Chronic diseases, including inflammatory bowel disease (IBD) urgently need new biomarkers as a significant proportion of patients, do not respond to current medications. Inflammation is a common factor in these...
6.
Jakharia A, Borkakoty B, Singh S
J Gastrointest Oncol
. 2016 Apr;
7(2):278-83.
PMID: 27034797
Background: SPARC-like protein 1 (SPARCL1/Hevin), a member of the SPARC family is defined by the presence of a highly acidic domain-I, a follistatin-like domain, and an extracellular calcium (EC) binding...
7.
Marimuthu A, Jacob H, Jakharia A, Subbannayya Y, Keerthikumar S, Kashyap M, et al.
J Proteomics Bioinform
. 2016 Apr;
4(4):74-82.
PMID: 27030788
Gastric cancer is the second leading cause of cancer death worldwide, both in men and women. A genomewide gene expression analysis was carried out to identify differentially expressed genes in...
8.
Asayesh-Ardakani H, Nie A, Marley P, Zhu Y, Phillips P, Singh S, et al.
Nano Lett
. 2015 Oct;
15(11):7179-88.
PMID: 26457771
There has been long-standing interest in tuning the metal-insulator phase transition in vanadium dioxide (VO2) via the addition of chemical dopants. However, the underlying mechanisms by which doping elements regulate...
9.
Kumar S, Mamidi P, Kumar A, Basantray I, Bramha U, Dixit A, et al.
Arch Virol
. 2015 Aug;
160(11):2749-61.
PMID: 26280524
Chikungunya virus (CHIKV) has reemerged recently as an important pathogen, causing several large epidemics worldwide. This necessitates the development of better reagents to understand its biology and to establish effective...
10.
Horrocks G, Singh S, Likely M, Sambandamurthy G, Banerjee S
ACS Appl Mater Interfaces
. 2014 Aug;
6(18):15726-32.
PMID: 25153653
VO2 nanostructures derived from solution-phase methods are often plagued by broadened and relatively diminished metal-insulator transitions and adventitious doping due to imperfect control of stoichiometry. Here, we demonstrate a stepwise...